Shu-nan N. Qi

Chinese Academy Of Medical Sciences And Peking Union Medical College
Beijing, 100021, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 114 publications

Efficacy and safety of neoadjuvant radiotherapy in patients with resectable hepatocellular carcinoma

Efficacy and safety of neoadjuvant radiotherapy in patients with resectable hepatocellular carcinoma

Journal: Zhonghua yi xue za zhi

Published: September 07, 2026

Comparative analysis of prognostic performance among different lymph node staging systems in gastric cancer

Comparative analysis of prognostic performance among different lymph node staging systems in gastric cancer

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: May 18, 2026

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

Journal: CA: a cancer journal for clinicians

Published: March 04, 2026

Prognostic and Treatment Values of Baseline Metabolic Tumor Volume in Early-stage Extranodal NK/T-cell Lymphoma in the Modern Treatment Era.

Prognostic and Treatment Values of Baseline Metabolic Tumor Volume in Early-stage Extranodal NK/T-cell Lymphoma in the Modern Treatment Era.

Journal: International journal of radiation oncology, biology, physics

Published: February 14, 2026

Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis.

Risk-Adapted Combined-Modality Therapy in Early-Stage Extranodal Natural Killer-/T-Cell Lymphoma: A Markov Model-Based Cost-Effectiveness Analysis.

Journal: JCO global oncology

Published: January 15, 2026

Failure patterns and clinical indications in early-stage follicular lymphoma: a study from the National Cancer Center in China.

Failure patterns and clinical indications in early-stage follicular lymphoma: a study from the National Cancer Center in China.

Journal: Frontiers in pharmacology

Published: November 12, 2025

A nomogram to predict pathological axillary lymph node status in neoadjuvant chemotherapy-treated patients with breast cancer.

A nomogram to predict pathological axillary lymph node status in neoadjuvant chemotherapy-treated patients with breast cancer.

Journal: Discover oncology

Published: October 25, 2025

Association of age and primary treatment with risk of non-lymphoma-related death and long-term survival outcomes in adult patients with early-stage follicular lymphoma: a population-based analysis.

Association of age and primary treatment with risk of non-lymphoma-related death and long-term survival outcomes in adult patients with early-stage follicular lymphoma: a population-based analysis.

Journal: Annals of hematology

Published: October 07, 2025

Preoperative short-course radiotherapy followed by chemotherapy and PD-1 inhibitor administration for locally advanced rectal cancer: the initial results of a randomized controlled clinical trial (STELLAR II)

Preoperative short-course radiotherapy followed by chemotherapy and PD-1 inhibitor administration for locally advanced rectal cancer: the initial results of a randomized controlled clinical trial (STELLAR II)

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: September 18, 2025

Advancing understanding of mature T-cell and natural killer-cell lymphomas.

Advancing understanding of mature T-cell and natural killer-cell lymphomas.

Journal: The Lancet. Haematology

Published: August 16, 2025

Optimizing Cardiac Dose Prediction in Left-Sided Breast Cancer Radiation Therapy: Clinical Strategies for Identifying Beneficiaries of the Deep Inspiration Breath-Hold Technique.

Optimizing Cardiac Dose Prediction in Left-Sided Breast Cancer Radiation Therapy: Clinical Strategies for Identifying Beneficiaries of the Deep Inspiration Breath-Hold Technique.

Journal: Advances in radiation oncology

Published: July 27, 2025

Short-course-based TNT with or without PD-1 inhibitor for pMMR locally advanced rectal cancer: Phase 2 results of a randomized trial (STELLAR II).

Short-course-based TNT with or without PD-1 inhibitor for pMMR locally advanced rectal cancer: Phase 2 results of a randomized trial (STELLAR II).

Journal: Med (New York, N.Y.)

Published: July 04, 2025

Showing 1-12 of 114

Last Updated: 09/26/2026